In response to a significant ongoing disruption to the supply of Ramipril 1.25mg capsules, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 22nd April 2026, SSP087 provides that where supplies are available, but the prescription is for more than one month’s supply the total quantity [...]
The post SSP for Ramipril 1.25mg capsules issued appeared first on Community Pharmacy England.
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined January, February and March 2026 reimbursement prices for the following products to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has [...]
The post Retrospective reimbursement prices for January, February and March 2026 appeared first on Community Pharmacy England.
Pharmacy teams are reminded that the NHS prescription charge remains at £9.90 per prescription item for 2026/27. A Government press release (released on 21/11/2025) previously confirmed that the NHS prescription charge would be frozen for 2026/27, as well as the costs for prescription prepayment certificates (PPCs). The list of 2026/27 prescription-related charges are outlined below. NHS charges for [...]
The post NHS prescription charges remain at £9.90 appeared first on Community Pharmacy England.
23 new products (including those with multiple flavours) have been added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 April 2026. Community Pharmacy England, on behalf of pharmacy owners, applied to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA) for these products to [...]
The post 23 products added to the Discount Not Deducted (DND) list from April 2026 appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited) Drug alert number: EL(26)A/17 Date issued: 26 March 2026 Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information. DMRC reference number: DMRC-38614094 Marketing Authorisation Holder: Sandoz Limited Medicine Details Product [...]
The post MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited) appeared first on Community Pharmacy England.
Recent Comments